Health Care/Hospital

Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes

FAIRFIELD, N.J., 17 May, 2022  /PRNewswire/ -- Vela Diagnostics announced today the launch of its new PathoKey® MP UTI ID and AMR PCR Test for research use only (RUO*). This multiplex PCR-based test allows for the in vitro detection and differentiation of 14 pathogens that cause urinary tract in...

2022-05-17 22:00 2315

"VR Hands-On Training" -- Live-Action Clinical Training with Hand Tracking Selected as a Finalist for AWE Auggie Awards, the World's Biggest VR/AR Awards!

TOKYO, May 17, 2022 /PRNewswire/ -- Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke Joji; hereafter "Jolly Good"), is pleased to announce that the latest version of "VR hands-on training", live-action clinical training with hand tracking which is a new function of medical VR, has ...

2022-05-17 21:00 1833

Indonesia to lead explore ASEAN Health Sector Cooperation with the US

DENPASAR, Indonesia, May 17, 2022 /PRNewswire/ -- On the last day of the 15th ASEAN Health Ministers Meeting, the Indonesian Ministry of Health as the Co-chair of the ASEAN-US Health Ministerial Meeting led the cooperation talks in ASEAN member states andthe United States of America (the US). <...

2022-05-17 20:05 1660

KAZIA MARKS DIPG AWARENESS DAY; NEW PRECLINICAL DATA IN DIPG TO BE PRESENTED AT ISPNO CONFERENCE

SYDNEY, May 17, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late-stage, oncology-focused drug development company, marks 'DIPG Awareness Day' by recognizing the tireless work of global researchers in this disease, and by calling for an increased focus on childhood ...

2022-05-17 20:00 1649

GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia

SUZHOU, China, May 15, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter referred to as "GeneQuantum"), a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won...

2022-05-16 09:00 2169

Kintor Pharma Included in MSCI China Index

SUZHOU, China, May 15, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced today that the company's stock has been included in the MSCI China Index, e...

2022-05-15 18:28 3789

Dizal Announces New Data from the Phase I/II Study of Golidocitnib in Refractory or Relapsed Peripheral T Cell Lymphoma Selected for Oral Presentation at 2022 EHA Annual Meeting

SHANGHAI, May 13, 2022 /PRNewswire/ -- Dizal (SSE: 688192) will present the data from an ongoing phase I/II study of golidocitnib, a selective JAK1 inhibitor, in refractory or relapsed peripheral T cell lymphoma (r/r PTCL) in oral session at the 27th European Hematology Association 2022 (EHA2022)...

2022-05-13 19:09 2639

Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria

SHIJIAZHUANG, China, May 12, 2022 /PRNewswire/ -- Yiling Pharmaceutical disclosed Wednesday that it had received the medicine approval document for Lianhua Qingwen Capsules from the National Agency for Food and Drug Administration and Control (NAFDAC),Nigeria. The Product Category is Herbal and ...

2022-05-12 22:43 2439

Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress

SAN DIEGO, Calif., SUZHOU and SHANGHAI, China , May 12, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of can...

2022-05-12 22:01 2973

BIORCHESTRA Participated in Formulation and Delivery

BOSTON, May 12, 2022 /PRNewswire/ -- BIORCHESTRA is a leading RNA therapeutics company that develops novel RNA-based therapeutics and drug delivery systems for neurodegenerative diseases.  BBB penetration in vivo confocal microscopy clip BIORCHES...

2022-05-12 21:00 1779

Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery

TAIPEI, May 12, 2022 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWO.6838 ) and AimMax Therapeutics, Inc. ( United States) report successful top-line results from CPN-301, the first of two pivotal Phase 3 clinical studies of APP13007, a novelophthalmic...

2022-05-12 20:00 1437

A novel universal antiviral drug introduced in Korea

- Hyundai Bioscience launches CP-COV03 Phase 2 clinical trials - "To be an innovative medicine like penicillin that led to victory in the bacterial war" - Significant changes to the 'vaccine-dependent' virus response system SEOUL, South Korea, May 12, 2022 /PRNewswire/ -- The birth of a universa...

2022-05-12 18:19 3080

WESMYLE Launches UTC Pro Capsule-Shape Portable Sonic Electric Toothbrush on Kickstarter

Featuring a Capsule-shape design Electric Toothbrush with Built-In UVC-LED Sterilizer for a 100% Bacteria-Free Toothbrush HONG KONG, May 11, 2022 /PRNewswire/ -- UTC Pro, a professional-grade 100% bacteria-proof and rust-proof electric toothbrush that can be seamlessly operated from one single b...

2022-05-12 09:37 1634

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial

SHANGHAI, May 11, 2022 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects of its innovative small-molecule KCNQ2/3 selective opener (CB03), developed for the treatment of refractory epilepsy. CB03 is...

2022-05-12 08:00 1360

VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Thursday, May 12, at 8:30 a.m. U.S. Eastern Time AUSTIN, Texas, May 11, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the first quar...

2022-05-12 04:10 3402

Nicetown Customized Outdoor Curtains - Bring Customers New Choice

LOS ANGELES, May 11, 2022 /PRNewswire/ -- The beloved custom window treatment brand NiceTown announced the launch of a new collectioncustom outdoor curtains this month in a stylish new selection of solid and patterned colors to bring fun and charm to outdoor home decor. ...

2022-05-12 01:00 1899

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes.

PALO ALTO, Calif., May 11, 2022 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based biotech start-up in the field of GMP cell manufacturing CDMO, announced that the company, in collaboration with Genequest Inc., aTokyo -based direct-to-consumer genetic testing service provider, e...

2022-05-12 00:00 2102

Asia's first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts.

Revolutionary Ovarian Cancer Rapid Test Available Q4 2022 SINGAPORE, May 11, 2022 /PRNewswire/ -- Known as a pioneer in Asia's women's and fetal health industry,Singapore-based diagnostics developer, INEX Innovate has obtained a CE markfor its lead ovarian cancer product, the OvaCis® Rapid Test....

2022-05-11 22:00 2455

PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention

DAEJEON, South Korea, May 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that Dr.Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to par...

2022-05-11 20:00 2231

Foodmate Announced Opening of a New Factory

SHANGHAI, May 9, 2022 /PRNewswire/ -- Foodmate, an innovative Chinese enterprise engaged in R&D, manufacture and sales of a diversified product portfolio which includes natural, nutritious food ingredients such as Gelatin, Hydrocolloids, Collagen Peptides, Functional animal proteins, Calorie-free...

2022-05-10 21:29 2068
1 ... 158159160161162163164 ... 278